These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 385328

  • 1. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R, Brugarolas A, Hansen H, Cavalli F, Ryssel H, Siegenthaler P, Clarysse A, Renard J, Kenis Y, Alberto P.
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD, Baker L, Thigpen T.
    Cancer Treat Rep; 1981 Jul; 65(1-2):115-7. PubMed ID: 6261943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
    Vats TS, Lui V, Trueworthy R, van Eys J.
    Cancer Treat Rep; 1981 Jul; 65(1-2):121-2. PubMed ID: 6939482
    [No Abstract] [Full Text] [Related]

  • 7. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
    Thigpen JT, Samson MK.
    Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
    [No Abstract] [Full Text] [Related]

  • 8. Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
    Creagan ET, Eagan RT, Kvols LK.
    Oncology; 1981 Apr; 38(5):260-1. PubMed ID: 7196561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
    Vogl SE, Seltzer V, Camacho F, Calanog A.
    Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
    Ratanatharathorn V, Baker LH, Balducci L, Talley RW, Hoogstraten B.
    Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
    [No Abstract] [Full Text] [Related]

  • 18. Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases.
    Creagan ET, Eagan RT, Rubin J.
    Med Pediatr Oncol; 1979 May; 7(2):179-80. PubMed ID: 502975
    [No Abstract] [Full Text] [Related]

  • 19. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
    Thigpen JT, Al-Sarraf M, Hewlett JS.
    Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.